Clinical trial Recruiting at 1 site Interventional Ages 55 to 79

Olfactory Network Testing with Electro-acupuncture for Subjective Cognitive Decline

Official title: Efficacy and Olfactory Network of Electro-acupuncture for Subjective Cognitive Decline: A Multicenter Randomized Controlled Trial and fMRI Study

Run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · NCT06758154 · Data updated 2026-11-12

This study tests whether electro-acupuncture can help people aged 55–79 with subjective cognitive decline, by looking at changes in their brain’s smell-related networks.

Quick facts

Study typeInterventional
Ages55 Years to 79 Years
SexAll
Enrollment92 (estimated)
SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedDecember 28, 2024
Main results expectedDecember 31, 2027
Study endsJune 30, 2028
Registry record updatedAugust 27, 2026
Trial IDNCT06758154 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 55–79 with diagnosed subjective cognitive decline, right-handed, with at least 8 years of education, and able to undergo MRI.

Probably not a fit

Individuals with conflicting medical conditions, MRI contraindications, or those already receiving other interventions that could confound results may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will use a multi-center ambispective design to combine fMRI and EEG during an olfactory task with an Oddball paradigm, aiming to map spatiotemporal patterns of entorhinal circuit damage in SCD and develop a middle fusion model of vulnerable brain networks. The study compares active electro-acupuncture to sham acupuncture to see if targeted neural changes correlate with clinical markers. Eligibility focuses on adults 55–79 with SCD, right-handed, and with sufficient education, who can consent and tolerate MRI. The trial seeks to identify biomarkers that predict progression to Alzheimer’s disease and to explore individualized intervention targets. No results are reported yet, and the approach blends neuroimaging with traditional acupuncture therapy.

Why it matters

Potential benefit: If successful, participants could gain access to a therapy that modulates brain networks associated with early cognitive decline and helps identify those at higher risk of progression.

How similar studies have gone: Prior work suggests olfactory and entorhinal network alterations are linked to cognitive decline, but this exact combined fMRI-EEG olfactory task with electro-acupuncture is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Meet the diagnostic criteria for SCD diseases;
2. 55-79 years old;
3. ≥8 years of schooling;
4. Right-handed;
5. Sign the informed consent.

Exclusion Criteria:

1. Have received other antidepressant therapy or involved in other clinical trials in the previous 2weeks.
2. Infarct located in the left DLPFC.
3. Positive psychiatric history and major trauma exposure history, such as depression, epilepsy, etc., in the past.
4. Other serious concomitant diseases (aphasia, severe edema, venous thrombosis, arteriosclerosis occlusion, diabetic vascular disease, peripheral neuropathy, spinal lesions, brain trauma, intracranial infection, brain tumors, etc.) or secondary diseases (heart, liver, renal failure, etc.).
5. Infection around acupoints and/or intolerance to acupuncture manipulation.
6. MRI or rTMS contraindications (claustrophobia, metal implants, cochlear implants, impulsator, etc.).

Where it's running

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.